Support for preclinical research into countermeasures against COVID-19

Support for the preclinical development of therapeutics or vaccines to fight infectious diseases/pathogens such as SARS-CoV-2. (Clinical trials will not be supported.)

$4,050,000 (U.S. dollars)
Eligibility (if available)

Higher Education Institutions, Nonprofits and For-Profit Organizations,State Governments ini the US.

Eligibility notes
(Except "foreign components" as defined in the NIH Grants Policy Statement)
Date of announcement
Date application deadline